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Ob@ives. This study sought to determine whether the re- 
sponse to amrinone in patients with severe baseline left venttic- 
ular dysfunction can predict improvement in left veatrlcular 
ejection fraction after coronary artery bypass graft surgery. 
ikwkgmrd. previous studies have suggested that the inotropic 
response to dobutamine can identify viable myocardium in the 
setting of chronic coronary disease and left :Ventricular dysfunc- 
tion. However, increased oxygen demand stimulated by dobut- 
amine can lead to superimposition of ischemia on the hibernating 
state, potentially confounding interpretation of results. Amrinone 
is an inotmpic agent that does not critically augment myocardial 
oxygen demand and may be useful for identification of hibernating 
myocardium in the chronically ischemic state. 
Methods. Forty-four consecutive patients with coronary artery 
disease and left ventricular ejection fraction <40% referred for 
coronary artery bypass graft surgery underwent amrinone stimu- 
lation (1 mgkg body weight). Left ventricular ejection fraction 
was determined before amrinone stimulation, 20 min after infu- 
sion and 21 days after bypass surgery. 
The past decade has seen a growing appreciation of the clinical 
ir;nor:ance of hibernating myocardium in patients with severe 
left xntricular dysfunction and chronic coronary artery dis- 
ease. ‘The ability to differentiate viabie. reversibly hypokinctic, 
chronically ischemic myocardium from infarction or scar may 
have major clinical implications. It can allow identification of 
patients with severe left ventricular dysfunction who are likely 
to demonstrate an improvement in left ventricular function 
with coronary revascularization and thus are most likely to 
Resuhs. Baseline ejection faction was 28 2 7% (mean f SD). 
Ejection fractioa increased to 35 f 5% after amrinone stimulation 
(p < O&lOl) und to 33 f 69b after bypass surgery (p < O.tM@l). 
Postbypass ejection fraction was stgaifkaatly conelated wttb 
postamrinone ejection fraction (r = 0.65, p C 0.0001). Further- 
mnre, the change in ejection fraction from baseline to after bypass 
surgery was highly correlated with the change in ejection fraction 
after amrtnone stimulation (r = 0.75, p < O.OtMl). Of 13 pattents 
with an increase in ejection traction 210% after amrtnone, all 13 
had an increase of at least 8% and 11 (85%) of 13 had an tncrease 
>lO% after bypass surgery. In contrast, of 31 patlents wtth an 
increase in ejection traction <lO% after amrtnom, only 2 (6%) 
had an increase ?lO% (p < 0.0001) and 28 (90%) of 31 had an 
increase ~5% after bypass surgey. 
-.Augmentationofmpcardinlconbactionbyamlhmne 
in patients with chrooii coronaq artery disease and severe baseEne 
teft ventricular dysbnution predkts impmvement tn left ventrtcnbu 
ejection fraction after coronary artery bypass graft sutgey. 
(I Am Cdl Cadid 1996;28:1488-92) 
benefit from the risk of such procedures and possibly avoid the 
need for cardiac transplantation. 
It has been shown (l-S) that the inotropic response to 
dobuiautine can identify viable myocardium in the setting of 
coronary artery disease and left ventricular dysfunction. How- 
ever. the increased oxygen demand stimulated by dobutamine 
can lead to superimposition of ischemia on the hibernating 
state. confounding interpretation of the results. We undertook 
the present study to determin : whether an alternative inotrop- 
ic agent. amrinone, a drug that does not critically augment 
myocardial oxygen demand (6-l I). can be used to identify 
patients with chronic coronary artery disease and poor left 
ventricular function who will show improved ventricular func- 
tion after coronas rcva4arization. 
Methods 
Patient. Forty-four conwcutivr paticntl; with coronq ar- 
kr), d&a= (~711’; lumen diameter narrcmirig) and left 
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ventricular ejection fraction ~40% referred for coronary ar: Bbk 1. Hemodynamic Resp&e 11~ Amenone 
tery bypass graft surgeryxomprised the study cohort (38 men, HR RPP 
6 women; mean [?SD] age 64 ? 5 ye&, range 53 td 80): The 
SB;’ : ,DBP 
-- 
decision to perform coronary rev+xdrirization.was made by Baseline M,?U~ I I4 -c III 13 2: 4 9.8!7 f I.294 
the patient’s treating physicians. withbut knowledge.. of the 
After amrinonc 8x+5 IN?7 71 24 ‘9.160 It II62 
results of amrinone stimulation. No patient had other,forms of 
p value NS < 0.M ,- NS NS - 
cardiomyopathy, required valve reelacement surgery or had 
previous coronary bypass surgery. Forty-one patients (93%) 
had a history of angina pectoris, and 41 (93%) had a previous 
myocardial infiirction. 
Data presented arcmean value + SD. DBP = diastolic hlwd prcwre 
(mm Hg); SBP = systolic hlcud pr > ~3 uii (mm tig); IIR - Karl Me (bealrmin); 
RPP 7 ule-prcsure product (katsimin y mm Hg). 
Study protocol. The amrinone stimulation protocol was 
performed a mean of 30 z 12 days before coronary bypass 
surgery. Baseline left ventricular ejection fraction was obtained 
by radionuclide angiography (described later) before amrinone 
stimulation. Intravenous iniusion of 1 m& b&y weighi oi 
amrinone was then administered over 4 min, with electrocar- 
diographic (ECG) and blood pressure monitoring (12). Twenty 
minutes later, postamrinone radionuclide angiographic left 
ventricular ejection fraction was obtained. Radionuclide an- 
giography was repeated 21 days after coronary bypass surgery. 
Radionuclide angiograpby. Gated equilibrium radionu- 
elide xgiogaphy was performed in the supine positinrl with 
standard techniques using red blood cells labeled in vivo with 
25 mCi of technetium-99m. Acquisition of data was performed 
with a standard Anger G:intillation gamma camera (Elscint- 
Apex 415)? equipped with a high sensitivity parallel-hole 
collimator. A total of 2oO.OW counts/image acquisition was 
obtained in a 64 X 64 matrix in 24 frames/cardiac cycle. Left 
ventricular ejection fraction was determined using the left 
anterior oblique projection that best separated the right and 
left ventricles. Left ventricular ejection fraction was deter- 
mined from background-corrected end-diastolic and end- 
systolic counts derived from semiautomated regions of interest. 
Coronary revascularization. All patients underwent stan- 
dard saphenous vein and internal mammary artery bypass 
grafting on the basis of the clinical decision of the treating 
physician and surgeon and without knowledge of the results of 
amrinone stimulation. Bypass grafting was uncomplicated in all 
patients. with no evidence of perioperative myocardial infarc- 
tion by serial postoperative cardiac enzyme levels and ECG 
results. 
Statistiad analysis. Data are presented as mean value 2 
SD. Left ventricular ejection fraction after amrinone stimula- 
after coronary bypass surgery described in the text refer to 
“ejection haction units” rather than a relative pxentage. Thus, 
a change of 20% to 30% is considered an increase of 10%. 
Results 
Hemalynamic response to amrinone. The hemodynamic 
response to amrinone is shown in Table 1. There was a small 
decrease in systolic blood pressure, whereas heart rate and 
diastolic blood pressure showed no significant change. Rate- 
pressure product (heart rate :+q ++olic blood pressure) also 
showed no change with amrinnne administration. 
No significant adverse effects occurred during or after 
administration of amrinone, including chest pain or ECG 
changes, and no study was discontinued because of secondar), 
effects. Ventricular premature beats (L.own class 1 to 2) were 
observed in five patients (11%) during the study f rotod 
However, four of these patients had a previous history of 
ventricular ectopic activity. No patient had ventricular tachy- 
cardia or fibrillation during the amrinone protocol. 
LeR ventricular hmetion response to amrinone. Baseline 
left ventricular ejection fraction was 28 z 7%. Left ventricular 
ejection fraction was c-309 in 26 patients (59%) and <,m in 
8 (18%). Individual data points for baseline. postamrinone and 
postbypass surgery left ventricular ejection fraction are shown 
in Figure 1. After administration of amrinone. mean left 
Fire 1. Relation of baseline and postamwone (AMR) ejection 
fraction (EF) before and after coronary art:: bypass urgc~ (C.4BG). 
Postamrinone ejection fraction corr+.~d stro@y wiih psthpau 
ejection frwrion (r = 0.65. p =C ‘1 &Ol). whereas haselirlr cjertion 
fraction correlared weakly (r = !,.31. p < 0.05). 
50 -- -__ ---...--- .--- - - _- 
tion and bypass surgery was compared with baseline ejection : ._.. 2 ,’ 
fraction using a paired I test. Pearson’s correlation was used to ‘2 
_ ; AA. .f.-. 
43 
;.’ . 
examine the association between ejection fraction after bkpass k I A ;i.xf’ta * 
surgery and after amrinone stimulation; baseline ejection 8 _ . . 2 l , ~~~.~z- ‘;A 
tractlon and cjcction fraction after bypass surgery: change in 9 30 ?.A- ‘- l A . 
ejection fraction after bypass surgery and after amrinonr $ .I 
xA.-‘i. ‘AA- - 
8 
Y,‘ -<.-‘“a _- - &A 
. . 
stimulation: and haxline ejection fraction and change in 20 : * ejection fraction after bypass surgery. Proportions of patients _.- _’ 
were compared using chi-square analysis. Predictors oi post- _:. 
bypass ejection frxtion were rvaluatcd using multivariate 
strpise regr&on ,f clinical hemodynamic and ejection 
fraction variablr?. A p vslue <(J.UC was cwnsidered significanl. 
Change- in cjcctna fnccfitm during amrinone stimulation and 
,o -: _..... _ .-.-.. .--..-._. .-_ _... --.. .-.-.---- -..~-~ -- 
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Figure 2. Relation of change (9) in ejection fraction (EF) with 
amrinonc stimulation 10 improvement in ejtxlion frxtion after core- 
nary artery bypaPs graft sxgery (C’.BG). There was a :;:rong correla- 
tion (r = 0.75, p ( O.J’*‘; i. 
ventricu’ral ,a’ -,I .I fraction increased IC) 35 k 5% (p < 
~l.ll(Ol). Left ventricular ejection fractm ixreased by ZW in 
17 patients and by ~10% in 13. 
Change !-I left ventricular ejection frxtion with amrinone 
was not related to any clinical variable, baseline heart rate or 
blood pressure or to the rate-pressure product response lo 
amrinone. 
Left ventricular hmction after coronary artery bypass graft 
surgery. After coronary artery bypzss graft surgery, left ven- 
tricular ejection fraction was 33 ? 6% (p < 0.0001 vs. 
baseline). Postbypass left ventricular ejection fraction was 
significantly correlated with postamrinone left ventricular ejec- 
tion fractic‘a (r = 0.65, p < fl.0041) and weakly correlated with 
baseline left ventricular ejection fraction (r = 0.31. p < 0.05) 
(Fig. 1). Furthermore, the change in left ventricular ejection 
fraction from baseline to after bypass surgery was highly 
correlated with the change in left ventricular ejection fraction 
from baseline to after amrinone (r = 0.75, p < 0.0001) (Fig. 2). 
In addition. the change in left ventricular ejection fraction 
after bypass surgery was inversely correla!ed with baseline lett 
ventricular ejection fracrion (r = -0.61. p < 0.0001 j (Fig. 3). 
Figure 3. R&ion of improvrment (A) in ejection fraction (EF) after 
bypass :xFq (CABG) 111 baseline ejection fraclion. Thcrc ~3s a 
signifkmt Inverse eorrr!okn (r = 0.6 i. p .: MM001 J. 
25 . 
-5 .. l I. 
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Figure 4. Frequency of improvement in ejection fraction (EF) of at 
least 10% after bypass surge? (CABG) as a function of ejection 
fraction rqonse 10 amrinone. The frequency of improvement in 
ejection fraction of at least 10% after bypass surgery was greater in 
patients (PTS) showing a ~10% increase ( t ) in ejection fraction with 
amrinone than in kosc with a <IO% increase with amrinune (p < 
0.0001). Wi = with. 
Of 13 patients with an increase in left ventricular ejection 
fraction ~10% after amrinone, all 13 had an increase in left 
ventricular ejection fraction of at least 8%. and 11 (85%) had 
an increase ~10% after bypass surgery (Fig. 4). In contrast, of 
31 patients witn an increase in left ventricular ejection fraction 
<IO% after amrinone, only 2 (6%) had an increase 210% 
after bypass surgery (p < O.ooOl vs. patients with increase in 
left ventricular ejection fraction 210% after amrinone) (Fig. 
4): r;nd 28 (90%) of 31 had an increase in left ventricular 
ejection fraction <5% after bypass surgery. 
Srq~~isc mt/ti~miu/e rcg~~ssion urrohsis of clinical data, 
hemodynamic variables and baseline and postdmrinone left 
ventricular ejection fraction found that the only significant 
predictors of postbypass left ventricular ejection fraction was 
postamrinone left ventricular ejection fraction (p < 00001) 
and rest systolic blood pressure (p ( 0.05). 
Discussion 
Since Rahimtoola (13) first introduced the concept of 
“hibernating myocardium” in 1985 on the basis of his obser- 
vatiorls that patients with depressed left ventricular ejection 
frxtiori who undewent coronary artery bypass graft surgery 
showed a recovery of left ventricular function. a new perspec- 
tivc for the treatment of patients with gverely impaired 
ventricular function due to coronary heart disealie has gradu- 
ally emerged. Whereas physicians were previously icluct,ant to 
recommend coronary artery bypass graft surgery to patients 
with poor left ~c~~ricular function becapse of a perveived high 
risk of surge:) .md lack of hen :lii. it is now recognized that an 
important subgroup of patients wit\ chronical& ikhemic. 
hibernating ,l,!aysrJiurn will \how important iecove~ of bcn- 
tricular functil!: with corona@ rcsasculartiation. nus. pa- 
tients form+ tto~ ;ht ‘Ill be terminal or referred to await 
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cardiac transplantation (often greatly !imited by, inadequate 
donor supply) now may be candidates for bypass, surgery if they 
can be demonstrated to have significant residual viable myo- 
cardium. The current challenge is to develop techniques 
capable of identifying such patients who would most likely 
benefit from bypass surgery. 
Because of the low predictive value of symptoms. ECG 
results or isolated wall motion analysis for the detection of 
viable myocardium (14) protocols involving functional meta- 
bolic studies using radionuclide methods have been recently 
explored (15-26). Advances in technology, such as positron 
emission tomographic scans with metabolic imaging. have 
shown the existence of severely hypoperhrsed, hypokinetic or 
akinetic myocardium that still has preserved glucose metabo 
lism and therefore viable tissue that potentially can recover its 
function if blood flow is restored (15.19-26). Thallium-201 
perfusion imaging with late redistribution, reinjection and 
rest-redistribution protocols currently receive the most wide- 
spread use in nuclear cardiology laboratories for assessing 
myocardial viability (15-19). Recently, dobutamine has also 
been used to detect viability (l-5). Because of its minor effects 
on heart rate and blood pressure, amrinone may have some 
advantages in the evaluation of hibcmating myocardium by 
lessening the likelihood of superimposing ischemia onto its 
inotropic effects. However. to our knowledge, amrinone has 
not been previously evaluated for this purpose. 
The results of the present study suggest that amrinone is 
helpful in detecting the presence of hibernating myocardium 
and in identifying the subgroup of patients with chronic 
coronary artery disease and severe left veutricular dysfunction 
who will show significant improvement in left ventricular 
function with roronary revascularization. The change in left 
ventricular ejection fraction with amrinone infusion strongly 
predicted the improvement in left ventricular ejection fraction 
after coronary artery bypass graft surgery (Fig. 2). An 
amrinone-induced increase in left ventricular ejection fraction 
~10% was observed in 13 (30%) of 44 patients and was 
associated with an 85% likelihood of a similar increase in left 
ventricular ejection fraction after bypass surgery (11 of 13 
patients) (Fig. 4). In contrast, such an improvement was Seen 
in only 2 (6%) of 31 patients after bypass surgery with a ~10% 
increase in left ventricular ejection fraction with amrinone 
(Fig. 4); 28 (90%) of 31 had a ~5% increase in left ventricular 
ejection fraction after bypass surgery. The sensitivity and 
specificity of an amrinone-induced increase in left ventricular 
ejection fraction ~10% for predicting a similar improvement 
after bypass surgery was 8S? and 945;. respectively. The 
improvement in left ventticular ejection fraction after bypass 
surgery wasinversely raitated to the baseline left ventricular 
ejection fraction (Fig. 3). suggesting thit even patients with 
very poor left ventricuiar function should be considered for 
coronary revascularization if they can be demonstrated to have 
recruitable function with inotropic stimulation. 
Amrimae e&d as dbility &her. The pharmacologic 
actions of amrinone involve both direct positive inotropic and 
direct systemic vasudilator actions. They are mediated by 
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inhibition .of phosphodiesterase III. which regularly degrades 
intracellular cyclic adenosine monophosphate (AMP) (27-29). 
Because of intracellular increases in cyclic AMP! more calcium 
is available, resulting in an enhanced inotropic state (27-29). 
In experimental models, amrinone demonstrates a.direct ino- 
tropic action, with no significant increase in oxygen consump- 
tion (7,30-32). reaching a maximal effect 20 min after admin- 
istration (31). It has also been demonstrated (29) that the 
initial inotropic changes greatly outweigh the peripheral ac- 
tions of amrinone. Moreover, 20 min after administration a 
significant decrease in vasodilation occurs without changes in 
inotropic stimulation (29). Thus, the primary response in left 
ventricular ejection fraction that we observed is most likely due 
to an increase in intrinsic contractile state in dysfunctional but 
viable hibernating myocardium. In this way, the response to 
amrinone is similar to dohutamine stimu!ation. Amrinone was 
thosen for our protocol because, unlike dobutamine, it causes 
.n lima1 changes in heart rate and systolic blo,xl pressure, 
resulting in no change in myocardial oxygen demand during its 
administration. Previous studies have demonstrated (33,34) 
that during dobrltamine stimulation, viable myocardium sup- 
plied by coronary artcri .s with significant lesions may demon- 
strate a “biphasic response” of initial augmentation in function 
followed by deterioration as the dose is increased. However. 
akinetic but viable myocardmm may show no augmentation of 
function even at low doses of dobutamine (35) which may lx 
attributable to development of ischemia induced by the hemo 
dynamic effects of dobutamine (34). Thus. this agent may 
underestimate myocardial viability. In the present study. am- 
rinone cdused no significant increase in any dete.minam of 
myocardial oxygen demand. Thus, i: may be possible to avoid 
the confounding development of superimposed acute ischemia 
by increased oxygen demand in the setting of restricted blood 
flow tha., may occur with dobutamine. In this way, amrinone 
may have theoretic advantages for the detection of hibernating 
myocardum over lobutamine. which causes significant dose- 
dependent inc.,, ---ses in heart and blood pressure afong with its 
inotropic stimulation. Further studies directly cc,mparing the 
two agents are needed. 
The pathophysiologic basis for recruitment of myocardial 
contractility in the setting cf hibernating myocardium. without 
increasing myocardial oxygen demand and inducing ischemia. 
remains unclear. It is possible that a!ternative energy rxtrac- 
tion metabolic pathways may e.xist or that vasodilation of the 
microcirculation occurs. which may improve energy supply 
without major oxygrn consumption demand incrzap+ 
Limitation of the study. A randomized design was not utid 
to select patients who underwent coronary artery bypass graft 
surgery, Patients were selected on the basis of the c!inical 
judgment of the treating physicians. However. physicians had 
no knowledge of the results of the amrinone stimulation test. 
thus. no bias is attributable to :he test. 
Cwdusions. The prevnt study demonstrdtrs that’ aug- 
‘mcntation of myocardial contraction by the inotropic agent 
amrinone in patients with chronic coronav anee disease and 
were left ventricular dysfuncti(~n predicts improvement in left 
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ventricular ejection fraction after coronary artery bypass graft 
surgery. Silch ‘In approach may bc a valuable adjunct to the 
selection of paiients with poor vcntricu;ar function ?nd chronic 
coronary artery disease who may be most likely to benefit from 
&Mary revascularization. 
---~..-- --__- 
WC thank Pam Vacck. PhD for rxccllcnt help wiIh s~ati~ii.;cl dnuly\is of Ihc data 
and Bonnie Wchh for cxpcrt sccrclariar assirtoncc wii;r the preparation of the 
manuscripl. 
JAt-C Vol. 2W. Nn. 6 
Nwcmhcr 15. I9%:MttR-92 
References 
I. Cigarroa CG. DrFillipi CR Brickncr ?,!E. et al. lnotropic c nIr:~~.!ir~* rLrrvc 
during dohuIamtnc stress cchocadiography prcd;cts rccovcry of rqional lcfr 
vcnlricular function iIfltX coronq riv.r&nriz&,!1 <‘ir~;:l:rlion 1993:~: 
UII-h. 
2. Marrullo P. Parodi 0. Rrisnhofcr B. cl al. V.duc of rest thallium-2tlli 
IcchnrIium-Wm xstamihi scans rind dohulanunc schtr.rrdiogrrphy for 
dcIcc!ing myocardial viability. Am J Cardiol IYY!:7l~l66-72. 
3. 1;i Canna G, Alficri 0. Giuhhini R. Gargano hl. Fcrrari R. Visioli 0. 
Echocardiography iuii,rg infusion rrI d.rh:I;rmlnc . . . I*\- if ylik*lif)n of rc. 
vcrsihlc d+sfuncIion in pahcnis with chronr: coronas drtcr)’ dircaw. J Am 
Coil (‘ardiol lYU:!3:617-26. 
4. Amesc M. Corncl JH. Salustri A. ~1 al. Prediction of improvvcmcnt of 
regional IzfI ~:m!ricular function aftrr surgical revascularizatioa: a compr- 
ium of low-dose dohmamine crhocsrdiography wiIh “‘TI single-phoron 
emission compmcd tomography. Circulation IYYSY 1:2748-S?. 
5. Perronc-Filardi P. Pact L, Pra.iIaro M, cl al. Dohutamine &ocardiography 
predicts improvcmcnt of hypopcrfuscd dysfuncrional myocsrdium after 
ruv~sculdrixalion in palicnls with coronary ~rtcry disease. CirculaIion IWS; 
Yl:2.5Sh-6s. 
6 BenotIi JR. Grossman W. Braunwald E. Ed al. Hcmodynamic asscssmcnt of 
amrinonc: b new irunropic agent N Engl J Mcd 1978:2W:l373-7. 
?. BcnoIii JR. Grossman W. Braunwald E, Carahcllo 9A. Flfuc~s of amrinonc 
rnr myocardial cncrgy mclaholism and hcmodynamics m psticnls with wvcrc 
congcstivc heart failure IO coronary artcry disease. Circulation 19Wl:62:28- 
34. 
H. Naccarclli GV. Gray EL. Doughrrty AH. rt al. Amrinonc: acute clcctrr~ 
physiologic and hcmodynamir ctkcrs in palicnls with congesfivc hcarI 
failure. Am J Cardiol lYiW:S4:MWl-4. 
Y. IiarIman A. Saccd M. Phosphodieslcrdsc inhihirion in positive inolropic 
Ihcrapy of congeslivc heart failure. J Appl Cariiol lYll6:1:361. 
IO. Gtrncn M. Pedcmonk 0. Back P. Co1 J. Amrinonc in Inr: managemen of 
low cardiac oulpul after open hcan surgery. Am J Cardicl iYHS:Sh:33B3gB. 
I I. Taylor SH, Vcrma SP. Hussian M. cl al. InIravcnou~ amrinone in left 
vcnlricular failure romplicalL~ by XUIC myocardial infarction. Am J Cardiol 
lYgS;Sh:?YE32B. 
I?.. Cragnolino D, DiLeiva A. Masoli 0. cl al. Vilhilidad m.iocardica: cual es cl 
apremis farmacologico a clegir? Rev SW Ar,cL‘nI Cm!h~! lWS;63:Y31lll 
13. Rahim:tnla SH. A pcrspccIive on the Ihrcc iargc muhircntcr randomized 
-rinka! trials of coronary artery bypass surgc9 for chronic sI;rhk angina, 
: irculaliun lY85:72123. 
I*. hoIo RW. Kowalchuck GJ. The ischcmit ;zscaJr: tcmprral scqucncc of 
hcratrdynamin. clcctrocardiographic and scinIum.rti. cxprr~siorr of rs&cmi;r. 
Am J C’ardrol lYti7:59:23C 
IS. Borrow RO. DrIririan V, Cuocolo A B;r<hararh SL. ldcntihcation of viahlc 
mytrardium in palienh with chronic coronary 
venlricular dysfunction. Circulahon lWl;H3:26-37. 
ar.;rv disease and lcf1 
16. Gioia G. Powcra J. Hco J. lskandrian AS. Rusuzl, 1. Cassl D. Pmgnostic 
value of rest-rcdistrihution Iomographic thallium-201 imaging in .ischemic 
cardiomyopalhy. Am J Cardiol lYYS:7S:7S9-62. 
17. Dilrizian V. Smcltzcr WR. Freedman ,NMT. Dcnras R; Borrow RO. 
Thallium rcinjection after strcsz-rcdistrihution imaging: dots 24hour de- 
laved imaging 3fIer rcinjcclion cnhancc &tcc!ion of viahlc myocardium? 
CirculaIion lWl:83:1?47-55. 
Id. Dilairian V. Frccdnran NMT. Bacharach SL. Pcrrone-Filardi P. Borrow RO. 
Regional thallium uptake in irrcvcrsihk defcclr: magnitclk of change in 
thallium ac:hrIy afIcr r&rjccIion disIinguirhcs viable from nonviahlc w 
cardium. Circulation lW?:SS:h27-X 
19. Dilrizian V. Purron:-Fi!rrdi P. Arright JA. et al. Concordance and discor- 
dance hebvccn stress-rvdisIrihutiorr-rcinjcction and rest-rcdistrihution tbal- 
lium imaging for assessing viabk myocardium: comparison with rrmtahdk 
activny hy positmn emission tomography. Circulation lW3:x8:941-52. 
211. Phrlkrt HR. Phclps ME, Hoffman E. Huang SC. Kuhl DE. Rcgional 
myocardial hlood flow. metabolism and furtction aa& norrinvasively with 
posrlnm cmitiion Iomography. Am J Cardiol 19WkfUkl269-77. 
2:. hlanhall RC. rillisch JH. Phelp ME. CI al. (dcnIibcatron and ditTtrrenIiation 
of rccting myocardial ischemia and infarclim in man with positmn computed 
Iomography, ‘*F-lab&d fluorodeoxygluc+c and N-13 ammonia. Cimrlatioo 
lW3;67:766-78. 
22. Tillisch JH. Brunkcn R. Marsha!! R. cl al. Rcvcnihility of cardiac anll- 
mofron ahnormaliIics prvdicled hy pusiiron tomography. N Engl J Med 
IUuv1IP.~-~. 
23. Brunkrn R. Tillisch 1. Schwaigur ht. ct al. Regional perfusion, gkrose 
mclaholism and wdll morion in palicnts with chronk electrocardiographic Q 
wave infarctions: cvidcncc for per&terra: of viahk tissue in some infan 
regions hy posiImn emission tomography. Circulation 19%739Sl-63. 
24. Schclbert HR Brrston D. Insights into coronary artery disease gained from 
melabulic imaging. Circulation 19X11;7R:4%-StlS. 
2S. Fudo T. Kamhara H. Hashimoto T. cl al. F-IX dcoxyglucosc and xtress N-1: 
ammonia positron emission tomography in anterior wall hcalud rnyoc&al 
infarction. Am J Cardud I9XX:61:1191-7. 
26. Tamaki N, Yonckura Y. Yamashita K. et al. Positron emissioo toqpaplq 
using Ruorinc-IX dcoxygluccnc in evaluation of comnary artery byptraa 
grafting. Am J Cardiol 1989:64:860-S. 
27. Honcr Jugcr P. Shafer -Koriing M lnvolvcmcni of cyclic-AMP in ~hc direct 
inotropic action of amrinonc. Naunyn !khmicdebcrgs Arch Phartttacol 
19t(l:318:11?. 
2N. Bairn DS. Effect of phosphtnliestrrasc inhihitkm on myocardial oxygen 
consumption and coronary blood flow. Am J Cardiol lm63:23A-6A 
29. Mancini D. LeJcmtcl T. Sonncnhlick E. Intravenous use of arririnone for the 
trcatmcnt of Ihc failing heart. Am J Cardiol 19f&S6:RB-ISB. 
311. Pm7 Balino N. Masoli 0. ct al. Tcs~ de csrimulacion con amrincrne: tma 
apmximacion diagnostica para la dctcLrion de viabilidad mitwardica. Rev 
Sot Argcnt Cardiol 19Y2;ho:2S7-U. 
31. JrnItcr JH, Lcjemkl TH, Sonnenhlick EH. Kirk ES. Bencluial effect of 
amrinonc on myocardial oxygen consumption during acute lcti ventricular 
failure in dogs. Am J Cardiol 19Hl:4lk7.5-Xl. 
32. Silver PJ. Biochemical aspcc~s of inhibition of cardiovascular low (&) cyclic 
adenosine monophosphate phosphodic?ilcrasc. Am J Cardiol l’)89,b3:2A- 
HA. 
33. KuI b. Thcrc may bc more’ to viability than meets 11 : eyr! Circulation 
IWS;L)I:?7W-3. 
.U. Kaul S. Rcsponsc of dysfunctional myocardium to dobutaminc. J Am 
Carditrl 1996:27:lMlH-11. 
35. Elhcndy h Come1 JH, Roclandt JRTC. ct al. Relation beovecn contractile 
response of akinctic xgmcnls during dobutaminc slress echocardiography 
,and myocardial irzhemia asses+zd hy simultaneous thallium-201 single 
phoIon emission computed tomography. Am J C’ardiol 1~77z9S.C9. 
